Fasciola hepatica is the mammalian liver parasite and it produces the result of poor welfare and economic losses in ruminants. While the number of eggs stool is the most common test used for diagnosis, it does not indicate a migration of the adult stage. serological techniques improve the sensitivity at all stages of liver fluke infection. The purpose of this study was to compare four commercially available ELISA test for the diagnosis of F. hepatica.

To this end, we tested three types of samples; (I) is known F. hepatica Status sera from experimental infection for the comparison of sensitivity and specificity, (ii) sera from pre- and post-flukicide-treated (albendazole, closantel, nitroxynil and triclabendazole) beef cattle seropositive for contrast difference before and after treatment, and (iii) samples of bulk tank milk samples from dairy cattle during periods of exposure to high and low F. hepatica to assess seasonal variation with four tests available.

Samples were assayed using ELISA kit provided by four manufacturers (Ildana Biotech, IDEXX, Svanova, and Bio-X). Samples were analyzed simultaneously and in duplicate.In Ildana population control, IDEXX and Bio-X presented 100% sensitivity (Se) and specificity (Sp), Svanovir served Se and Sp of 59% from 96%. In flukicide-treated beef, kit highlighted a decrease in antibody levels 90 days post-treatment in variable degrees.

Finally, bulk milk showed a significant decrease in the value of ELISA between periods of high and low exposure to coincidence with all tests and Sp studied.Se found in this study, confirming that Ildana, IDEXX and Bio-X accurate for detecting exposure to F. hepatica in cattle Ireland. Svanovir Se and Sp in this population, suggesting that larger studies are needed to confirm the characteristics of these tests in the herd of Ireland.

In the use of post-treatment, Bio-X showed a consistent and significant reduction of the value of the ELISA in all treatment groups, which were shown to be a reliable tool to assess the effects of treatment on day 90 post-treatment. Finally, all tests showed to be a reliable tool for monitoring F. hepatica high season and low exposure, using bulk tank milk samples.

Improved diagnosis of diabetes type Japanese-onset autoimmune first time using a new ELISA kit GADAb, compared to the previously used GADAb RIA kit.

We compared the results of glutamic acid decarboxylase antibody test (GADAb) using radioimmunoassay (RIA) and enzyme-linked immunosorbent assay (ELISA) in subjects with age-onset diabetes mellitus type 1 specimen (T1D) .Serum collected from 1024 cases of Japan (426 laki- male and 598 female) in 2013. the average age of diagnosis was 7 years (0-18 years).

Blood specimen obtained at a mean age of 13 years (2-22 years) .Among 628 subjects whose serum specimens collected within 5 years after diagnosis, positive GADAb level is 47.9% and 69.4% using a RIA using ELISA. The subjects were divided into four groups according to their RIA and ELISA results for GADAb as follows: Gr I (RIA + / ELISA +), Gr II (RIA + / ELISA-), Gr III (RIA- / ELISA +) and Gr IV (RIA – / ELISA-).

Clinical characteristics and genetic Gr Gr I and III were very similar in terms of age at diagnosis, male / female ratio, a relatively high positive rate for both IA-2AB and ZnT8Ab, and HLA genotype. Gr II only contains 5 patients and is characterized by a younger age at diagnosis, a low positive rate for both IA-2AB and ZnT8Ab and unique HLA genotype.

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381198-5x01mgWithoutBSAAzideat1mgmL	MyBiosource	5x0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 1725

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-002mgWithBSAAzideat02mgmL	MyBiosource	0.02mg(WithBSA&Azideat0.2mg/mL)	EUR 230

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-01mgWithBSAAzideat02mgmL	MyBiosource	0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 405

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-01mgWithoutBSAAzideat1mgmL	MyBiosource	0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 405

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-5x01mgWithBSAAzideat02mgmL	MyBiosource	5x0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 1725

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)
MBS4381199-5x01mgWithoutBSAAzideat1mgmL	MyBiosource	5x0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-002mgWithBSAAzideat02mgmL	MyBiosource	0.02mg(WithBSA&Azideat0.2mg/mL)	EUR 230

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-01mgWithBSAAzideat02mgmL	MyBiosource	0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-01mgWithoutBSAAzideat1mgmL	MyBiosource	0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-5x01mgWithBSAAzideat02mgmL	MyBiosource	5x0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381128-5x01mgWithoutBSAAzideat1mgmL	MyBiosource	5x0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-002mgWithBSAAzideat02mgmL	MyBiosource	0.02mg(WithBSA&Azideat0.2mg/mL)	EUR 230

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-01mgWithBSAAzideat02mgmL	MyBiosource	0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-01mgWithoutBSAAzideat1mgmL	MyBiosource	0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 405

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-5x01mgWithBSAAzideat02mgmL	MyBiosource	5x0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 1725

YBX1/Y-box Binding Protein 1/YB-1 (Tumor Biomarker)
MBS4381129-5x01mgWithoutBSAAzideat1mgmL	MyBiosource	5x0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 1725

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL
BNUM2759-50	Biotium	1uL	EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL
BNUM2760-50	Biotium	1uL	EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL
BNUB2759-100	Biotium	1uL	EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL
BNUB2759-500	Biotium	1uL	EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL
BNUB2760-100	Biotium	1uL	EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL
BNUB2760-500	Biotium	1uL	EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-002mgWithBSAAzideat02mgmL	MyBiosource	0.02mg(WithBSA&Azideat0.2mg/mL)	EUR 230

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-01mgWithBSAAzideat02mgmL	MyBiosource	0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-01mgWithoutBSAAzideat1mgmL	MyBiosource	0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-5x01mgWithBSAAzideat02mgmL	MyBiosource	5x0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 1725

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380253-5x01mgWithoutBSAAzideat1mgmL	MyBiosource	5x0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 1725

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-002mgWithBSAAzideat02mgmL	MyBiosource	0.02mg(WithBSA&Azideat0.2mg/mL)	EUR 230

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-01mgWithBSAAzideat02mgmL	MyBiosource	0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-01mgWithoutBSAAzideat1mgmL	MyBiosource	0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 405

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-5x01mgWithBSAAzideat02mgmL	MyBiosource	5x0.1mg(WithBSA&Azideat0.2mg/mL)	EUR 1725

TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis)
MBS4380254-5x01mgWithoutBSAAzideat1mgmL	MyBiosource	5x0.1mg(WithoutBSA&Azideat1mg/mL)	EUR 1725

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL
BNUM2430-50	Biotium	1uL	EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL
BNUB2430-100	Biotium	1uL	EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL
BNUB2430-500	Biotium	1uL	EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 1mg/mL
BNUM2570-50	Biotium	1uL	EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL
BNUB2570-100	Biotium	1uL	EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL
BNUB2570-500	Biotium	1uL	EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), Biotin conjugate, 0.1mg/mL
BNCB2759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), Biotin conjugate, 0.1mg/mL
BNCB2759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), Biotin conjugate, 0.1mg/mL
BNCB2760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), Biotin conjugate, 0.1mg/mL
BNCB2760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF568 conjugate, 0.1mg/mL
BNC682759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF568 conjugate, 0.1mg/mL
BNC682759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL
BNC682760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF568 conjugate, 0.1mg/mL
BNC682760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL
BNC942759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF594 conjugate, 0.1mg/mL
BNC942759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL
BNC942760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF594 conjugate, 0.1mg/mL
BNC942760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF647 conjugate, 0.1mg/mL
BNC472759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF647 conjugate, 0.1mg/mL
BNC472759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF647 conjugate, 0.1mg/mL
BNC472760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF647 conjugate, 0.1mg/mL
BNC472760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL
BNC882759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF488A conjugate, 0.1mg/mL
BNC882759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL
BNC882760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF488A conjugate, 0.1mg/mL
BNC882760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL
BNC042759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF405S conjugate, 0.1mg/mL
BNC042759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL
BNC042760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF405S conjugate, 0.1mg/mL
BNC042760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL
BNC402759-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), CF640R conjugate, 0.1mg/mL
BNC402759-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL
BNC402760-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), CF640R conjugate, 0.1mg/mL
BNC402760-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 1mg/mL
BNUM1943-50	Biotium	1uL	EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL
BNUB1943-100	Biotium	1uL	EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), 0.2mg/mL
BNUB1943-500	Biotium	1uL	EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), Biotin conjugate, 0.1mg/mL
BNCB2570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF568 conjugate, 0.1mg/mL
BNC682570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF594 conjugate, 0.1mg/mL
BNC942570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF647 conjugate, 0.1mg/mL
BNC472570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402430-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402430-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF488A conjugate, 0.1mg/mL
BNC882570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF405S conjugate, 0.1mg/mL
BNC042570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402570-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), CF640R conjugate, 0.1mg/mL
BNC402570-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), Biotin conjugate, 0.1mg/mL
BNCB1943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), Biotin conjugate, 0.1mg/mL
BNCB1943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF568 conjugate, 0.1mg/mL
BNC681943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF568 conjugate, 0.1mg/mL
BNC681943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL
BNC881943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF488A conjugate, 0.1mg/mL
BNC881943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL
BNC941943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF594 conjugate, 0.1mg/mL
BNC941943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL
BNC041943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF405S conjugate, 0.1mg/mL
BNC041943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL
BNC401943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF640R conjugate, 0.1mg/mL
BNC401943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF647 conjugate, 0.1mg/mL
BNC471943-100	Biotium	1uL	EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis)(rTIMP1/1710), CF647 conjugate, 0.1mg/mL
BNC471943-500	Biotium	1uL	EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Her-2 IHC Bio-marker control TMA
Her2a	TissueArray	each	EUR 78
Description: Her-2 IHC Bio-marker control TMA, with breast invasive ductal carcinoma, including TNM, clinical stage and pathology grade, 10 cases/ 10 cores, replaced by Her2b

Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b
HER2c	BioCoreUSA	row: 3; column: 4; cores: 10; cases: 10	EUR 78
Description: Her-2 IHC Biomarker control tissue microarray of breast invasive carcinoma of no special type, containing 10 cases of invasive invasive carcinoma of no special type, single core per case

Rat Myosin-binding protein C, cardiac-type,Cardiac MyBP-C ELISA Kit
EK5119	SAB	96 tests	EUR 739

Rat Myosin-binding protein C, cardiac-type, Cardiac MyBP-C ELISA Kit
MBS9428945-5x96Tests	MyBiosource	5x96Tests	EUR 3385

Rat Myosin-binding protein C, cardiac-type, Cardiac MyBP-C ELISA Kit
MBS9428945-96Tests	MyBiosource	96Tests	EUR 735

Rat Cardiac Troponin ELISA Kit
MBS3809733-10x96StripWells	MyBiosource	10x96-Strip-Wells	EUR 6725

Rat Cardiac Troponin ELISA Kit
MBS3809733-48StripWells	MyBiosource	48-Strip-Wells	EUR 550

Rat Cardiac Troponin ELISA Kit
MBS3809733-5x96StripWells	MyBiosource	5x96-Strip-Wells	EUR 3420

Rat Cardiac Troponin ELISA Kit
MBS3809733-96StripWells	MyBiosource	96-Strip-Wells	EUR 765

Human Cardiac Troponin ELISA Kit
MBS3804762-10x96StripWells	MyBiosource	10x96-Strip-Wells	EUR 6725

Human Cardiac Troponin ELISA Kit
MBS3804762-48StripWells	MyBiosource	48-Strip-Wells	EUR 550

Human Cardiac Troponin ELISA Kit
MBS3804762-5x96StripWells	MyBiosource	5x96-Strip-Wells	EUR 3420

Human Cardiac Troponin ELISA Kit
MBS3804762-96StripWells	MyBiosource	96-Strip-Wells	EUR 765

Pig Cardiac phospholamban ELISA Kit
MBS288942-10x96StripWells	MyBiosource	10x96-Strip-Wells	EUR 4630

Pig Cardiac phospholamban ELISA Kit
MBS288942-48StripWells	MyBiosource	48-Strip-Wells	EUR 440

Pig Cardiac phospholamban ELISA Kit
MBS288942-5x96StripWells	MyBiosource	5x96-Strip-Wells	EUR 2480

Pig Cardiac phospholamban ELISA Kit
MBS288942-96StripWells	MyBiosource	96-Strip-Wells	EUR 580

Dog Cardiac phospholamban ELISA Kit
MBS2887029-10x96StripWells	MyBiosource	10x96-Strip-Wells	EUR 4630

Dog Cardiac phospholamban ELISA Kit
MBS2887029-48StripWells	MyBiosource	48-Strip-Wells	EUR 440

Dog Cardiac phospholamban ELISA Kit
MBS2887029-5x96StripWells	MyBiosource	5x96-Strip-Wells	EUR 2480

Dog Cardiac phospholamban ELISA Kit
MBS2887029-96StripWells	MyBiosource	96-Strip-Wells	EUR 580

Rat Cardiac phospholamban ELISA Kit
MBS2883742-10x96StripWells	MyBiosource	10x96-Strip-Wells	EUR 4080

Rat Cardiac phospholamban ELISA Kit
MBS2883742-48StripWells	MyBiosource	48-Strip-Wells	EUR 390

Rat Cardiac phospholamban ELISA Kit
MBS2883742-5x96StripWells	MyBiosource	5x96-Strip-Wells	EUR 2220

Rat Cardiac phospholamban ELISA Kit
MBS2883742-96StripWells	MyBiosource	96-Strip-Wells	EUR 520

Rat Cardiac Troponin I ELISA kit
E01A16855	BlueGene	96T	EUR 700
Description: ELISA

Rat Cardiac Troponin T ELISA kit
E01A16856	BlueGene	96T	EUR 700
Description: ELISA

Rat cardiac Troponin C ELISA kit
E01A12734	BlueGene	96T	EUR 700
Description: ELISA

Pig Cardiac Troponin I ELISA kit
E07T0016-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Cardiac Troponin I in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cardiac Troponin I ELISA kit
E07T0016-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Cardiac Troponin I in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cardiac Troponin I ELISA kit
E07T0016-96	BlueGene	1 plate of 96 wells	EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine Cardiac Troponin I in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cardiac Troponin T ELISA kit
E07T0017-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Cardiac Troponin T in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cardiac Troponin T ELISA kit
E07T0017-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Cardiac Troponin T in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cardiac Troponin T ELISA kit
E07T0017-96	BlueGene	1 plate of 96 wells	EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine Cardiac Troponin T in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig cardiac Troponin C ELISA kit
E07C2520-192T	BlueGene	192 tests	EUR 1524
Description: A sandwich ELISA for quantitative measurement of Porcine cardiac Troponin C in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig cardiac Troponin C ELISA kit
E07C2520-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A sandwich ELISA for quantitative measurement of Porcine cardiac Troponin C in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig cardiac Troponin C ELISA kit
E07C2520-96	BlueGene	1 plate of 96 wells	EUR 822
Description: A sandwich ELISA for quantitative measurement of Porcine cardiac Troponin C in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat cardiac Troponin C ELISA kit
E02C2520-192T	BlueGene	192 tests	EUR 1524
Description: A sandwich ELISA for quantitative measurement of Rat cardiac Troponin C in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat cardiac Troponin C ELISA kit
E02C2520-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A sandwich ELISA for quantitative measurement of Rat cardiac Troponin C in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat cardiac Troponin C ELISA kit
E02C2520-48wellsplate	BlueGene	48 wells plate	EUR 280

Rat cardiac Troponin C ELISA kit
E02C2520-96	BlueGene	1 plate of 96 wells	EUR 822
Description: A sandwich ELISA for quantitative measurement of Rat cardiac Troponin C in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat cardiac Troponin C ELISA kit
E02C2520-96wellsplate	BlueGene	96 wells plate	EUR 405

Rat Cardiac Troponin I ELISA kit
E02T0016-192T	BlueGene	192 tests	EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat Cardiac Troponin I in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Cardiac Troponin I ELISA kit
E02T0016-48	BlueGene	1 plate of 48 wells	EUR 624
Description: A competitive ELISA for quantitative measurement of Rat Cardiac Troponin I in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Cardiac Troponin I ELISA kit
E02T0016-48wellsplate	BlueGene	48 wells plate	EUR 280

If the positive rate of both IA-2AB or ZnT8Ab or both are added to the results GADAb using RIA, autoimmune T1D percentage increased from 47.9% to 78.5% .the diagnosis of autoimmune time-onset T1D Japan GADAb increased when the results obtained using the new ELISA method , compared with RIA method previously used.